Ye Xu
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 13
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 8
- Oncology top 5%
- Cancer-related Molecular Pathways 10
- Pharmacology top 5%
- Molecular Biology top 10%
- DNA Repair Mechanisms 14
- Epigenetics and DNA Methylation 7
- Genetics top 5%
- BRCA gene mutations in cancer 20
-
- Genetic factors in colorectal cancer 7
- Cited by
- Cancer ResearchOncologyPharmacology
- Journals
- Nature (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Ye Xu
89 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 666
- Oncology 568
- Pharmacology 134
- Molecular Biology 954
- Genetics 379
Countries citing papers authored by Ye Xu
This map shows the geographic impact of Ye Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Xu more than expected).
Fields of papers citing papers by Ye Xu
This network shows the impact of papers produced by Ye Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Xu. The network helps show where Ye Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ye Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2021 | 2 | |
| 4 | Improving The Oral Absorption Of Nintedanib By A Self-Microemulsion Drug Delivery System: Preparation And In Vitro/In Vivo Evaluation | 2019 | 1 |
| 5 | 2019 | 17 | |
| 6 | 2019 | 14 | |
| 7 | 2017 | 2 | |
| 8 | 2016 | 4 | |
| 9 | Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer. | 2015 | 12 |
| 10 | 2015 | 73 | |
| 11 | 2014 | 37 | |
| 12 | 2014 | 30 | |
| 13 | 2013 | 8 | |
| 14 | 2012 | 31 | |
| 15 | 2011 | 22 | |
| 16 | Study on the relation between TCM syndrome and metabolic syndrome of overweight and obesity patients. | 2010 | 1 |
| 17 | 2010 | 37 | |
| 18 | 2009 | 15 | |
| 19 | 2009 | 28 | |
| 20 | 2006 | 16 |
About Ye Xu
Ye Xu is a scholar working on Cancer Research, Oncology and Genetics, having authored 90 papers that have together received 1.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (20 papers), DNA Repair Mechanisms (14 papers), Cancer Genomics and Diagnostics (13 papers), Cancer-related molecular mechanisms research (10 papers), Cancer-related Molecular Pathways (10 papers), MicroRNA in disease regulation (8 papers), Epigenetics and DNA Methylation (7 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Cancer Research (666 citations), Oncology (568 citations) and Pharmacology (134 citations). Ye Xu has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Yuntao Xie, Zhaoqing Fan, Benyao Lin, Tao Ouyang, Jinfeng Li, Tie Fan, Tianfeng Wang, Tao Ouyang, Bairong Xia and Bo Lin. Their work appears in journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.